Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Chemmedchem|April 26, 2017
Immunogenicity of a Fully Synthetic MUC1 Glycopeptide Antitumor Vaccine Enhanced by Poly(I:C) as a TLR3-Activating AdjuvantMarkus Glaffig, Natascha Stergiou, Edgar Schmitt, et al.
Chemmedchem|December 2, 2017
A Synthetic MUC1 Anticancer Vaccine Containing Mannose Ligands for Targeting Macrophages and Dendritic CellsMarkus Glaffig, Natascha Stergiou, Sebastian Hartmann, et al.
Chemmedchem|July 5, 2017
Immunization with a Synthetic Human MUC1 Glycopeptide Vaccine against Tumor-Associated MUC1 Breaks Tolerance in Human MUC1 Transgenic MiceNatascha Stergiou, Markus Glaffig, Helmut Jonuleit, et al.
Chemical Record (New York, N.Y.)|November 23, 2021
The Development of Vaccines from Synthetic Tumor-Associated Mucin Glycopeptides and their Glycosylation-Dependent Immune ResponseNatascha Stergiou, Moritz Urschbach, Adele Gabba, et al.
Angewandte Chemie (International Ed. in English)|October 17, 2014
A fully synthetic four-component antitumor vaccine consisting of a mucin glycopeptide antigen combined with three different T-helper-cell epitopesBjörn Palitzsch, Sebastian Hartmann, Natascha Stergiou, et al.
Chembiochem : a European Journal of Chemical Biology|April 11, 2018
Synthetic MUC1 Antitumor Vaccine with Incorporated 2,3-Sialyl-T Carbohydrate Antigen Inducing Strong Immune Responses with Isotype SpecificityDavid Straßburger, Markus Glaffig, Natascha Stergiou, et al.
Chembiochem : a European Journal of Chemical Biology|March 11, 2015
Antibody induction directed against the tumor-associated MUC4 glycoproteinHui Cai, Björn Palitzsch, Sebastian Hartmann, et al.
Chembiochem : a European Journal of Chemical Biology|February 28, 2018
Mannose-Decorated Multicomponent Supramolecular Polymers Trigger Effective Uptake into Antigen-Presenting CellsDavid Straßburger, Natascha Stergiou, Moritz Urschbach, et al.
Advanced Healthcare Materials|October 21, 2014
CpG-loaded multifunctional cationic nanohydrogel particles as self-adjuvanting glycopeptide antitumor vaccinesSebastian Hartmann, Lutz Nuhn, Björn Palitzsch, et al.
Angewandte Chemie (International Ed. in English)|January 23, 2016
A Synthetic Glycopeptide Vaccine for the Induction of a Monoclonal Antibody that Differentiates between Normal and Tumor Mammary Cells and Enables the Diagnosis of Human Pancreatic CancerBjörn Palitzsch, Nikola Gaidzik, Natascha Stergiou, et al.
Pageof 3